3Kwon OS, Chung YB, Kim MH, et al. Pharmacokinetics of propentofylline and the quantitation of its metabolite hydroxypropentofylline in human volunteers[J]. Arch Pharm Res, 1998, 21(6):698.
4Krall WJ, Scramek JJ, Cutler NR. Prospects for pharmacological intervention in Alzheimer's Disease[J]. Ann Pharma, 1999, 33(4):441.
7McGeer PL, McGeer EG. Anti-inflammatory drugs in the fight against Alzheimer's Disease[J]. Ann NY Acad Sci, 1996, 777:213.
8Pieri C, Marra M, Gaspar R. Melatonin protects LDL from oxidation but dose not prevent the apolipoprotein derivatization[J]. Biochem Biophys Res Commun, 1995, 20:159.
10Klafki W, Paganetti PA, Sommer B, et al. Calpain inhibitor I decreases beta A4 secretion from human embryonal kidney cells expressing beta-amyloid precursor protein carrring the APP 670/671 double mutation[J]. Neurosci Lett, 1995, 201(1):29.
43，Takedo A, Yasuda T, Miyata T, et al. Immunohistochemical study of advanced glycationend products in aging and Alzheimer's disease brain. Neurosci Lett, 1996, 221：17-20.
54，Horie K, Miyata T, Yasuda T,et al. Immunohistochemical localization of advancedglycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments ofAlzheimer's disease and aged neurons. Biochem Biophys Res Commun, 1997, 236：327-332.
65，Niwa H, Takedo A, Wakai M, et al. Accelerated formation of Nepsilon-(carboxymethyl)lysine, an advanced glycation end products, by glyoxal and3-deoxyglucosone in cultured rat sensory neurons. Biochem Biophys Res Commun, 1998, 248：93-97.
76，Weber K, Schmahl W, Munch G. Distribution of advanced glycation end products in thecerebellar neurons of dogs. Brain Res, 1998, 791：11-17.
87，Vitek MP, Bhattacharya K, Glendening JM,et al. Advanced glycation end productsontribute to amyloidosis in Alzheimer's disease. Proc Natl Acad Sci USA, 1994, 91：4766-4770.
98，Mund G, Mayer S, Michaelis J, et al. Influence of advanced glycation end products andAGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. BiochemBiophys Acta, 1997, 1360：17-29.
109，Yan SD, Chen X, Schmidt AM, et al. Glycated tau protein in Alzheimer's disease: amechanism for induction of oxidant stress. Proc Natl Acad Sci USA, 1994, 91：7787-7791.
